Confronting the complexity of EGFR/HER targeted therapies in breast, colorectal and lung cancers

A panel of European experts met during the first ESMO Signaling Pathways Symposium on “Targeting the HER/EGFR family in breast, lung and colorectal cancers” (1-2 March 2013, Sitges, Spain) to discuss on current and emerging issues in targeting EGFR/HER pathway, and highlighting possible shared approaches in a context of personalised cancer medicine. Read the key points from the discussion here.